SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivanza Biosciences informs about scrutinizer report on e-voting

25 Feb 2023 Evaluate

Vivanza Biosciences has informed that it enclosed the Scrutinizer Report on the One Resolution passed at the Extra Ordinary General Meeting (EOGM) of the Company held on February 24, 2023 through Video Conferencing/Other Audio-Visual Means (‘VC/OAVM’). Further, the resolution has been approved by the members with the requisite majority.

The above information is a part of company’s filings submitted to BSE.



Vivanza Biosciences Share Price

2.07 -0.03 (-1.43%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 227.50
Adani Enterprises 2228.00
Amrapali Industries 17.36
Rashi Peripheral 474.40
PDS 294.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×